Monika Duszyńska as one of the authors of the standpoint of PTOK

In January 2018, “Hematologia” journal published the position of PTOK (Polish Society of Clinical Oncology) on the introduction of national standards for the use of biological medicines. One of its co-authors is Monika Duszyńska, who drafted the legal part on biological medicines and the principles of their substitution. From this year, clinical oncologists will have at their disposal biosimilar medicines with antineoplastic effect, which are comparators of original biological medicines already used in clinical practice. Biosimilar medicines provide real hope for reducing the costs of oncological treatment and restrictions on the use of biological medicines and increasing the possibilities of optimizing oncological treatment.
We invite you to read the full text at: https://journals.viamedica.pl/hematologia/article/view/57470 (english version)